In an 8.3‑kg infant receiving cycloserine, is a daily dose of 2.5 mL of Polynerve (pyridoxine 5 mg/mL) sufficient to prevent cycloserine‑induced neurotoxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pyridoxine Dosing for Cycloserine-Induced Neurotoxicity Prevention in Infants

No, 2.5 mL once daily of Polynerve syrup (providing 12.5 mg pyridoxine) is insufficient for an 8.3-kg infant receiving cycloserine; the infant requires 100–200 mg of pyridoxine daily to prevent neurotoxicity.

Recommended Pyridoxine Dose

  • Adults receiving cycloserine require 100–200 mg of pyridoxine daily to prevent and treat neurotoxic side effects, according to the CDC/ATS tuberculosis treatment guidelines 1
  • The FDA drug label for cycloserine states that 200–300 mg of pyridoxine daily can both treat and prevent many neurotoxic effects in adults 2
  • Pyridoxine should be administered routinely to all patients on cycloserine, as the value of pyridoxine in preventing CNS toxicity has been established in clinical practice 2

Calculation for This Infant

  • At 5 mg/mL concentration, 2.5 mL provides only 12.5 mg of pyridoxine daily
  • For an 8.3-kg infant, even using conservative weight-based dosing extrapolated from adult recommendations (approximately 12–24 mg/kg/day based on adult 100–200 mg doses for a 60-kg adult), this infant would require approximately 100–200 mg daily
  • The current dose represents only 6–12% of the recommended amount

Correct Dosing Strategy

  • Increase the daily pyridoxine dose to 100–200 mg (20–40 mL of the 5 mg/mL syrup) divided into 2–4 doses throughout the day 1
  • Start at the lower end (100 mg daily) and titrate upward if any signs of neurotoxicity develop 2
  • Monitor closely for neuropsychiatric symptoms including irritability, seizures, peripheral neuropathy, and developmental changes 2

Critical Monitoring Parameters

  • Assess neuropsychiatric status at least monthly and more frequently if any symptoms develop 1
  • Watch for early signs of cycloserine neurotoxicity: headache, vertigo, confusion, drowsiness, hyperirritability, paresthesias, and seizures 2
  • Cycloserine doses above 500 mg daily in adults (approximately 6 mg/kg/day) are associated with increased toxicity risk; ensure the infant's cycloserine dose is appropriate 1
  • Recent evidence shows that neuropathy occurred in 35% of patients receiving terizidone (cycloserine analogue) despite pyridoxine supplementation, emphasizing the need for adequate dosing 3

Important Caveats

  • Seizures from cycloserine toxicity require both anti-epileptics and pyridoxine for management 4
  • The protective effect of pyridoxine is dose-dependent; inadequate dosing will not prevent neurotoxicity 2
  • Paradoxically, very high-dose pyridoxine (200 mg vs 150 mg daily) has been associated with increased neuropathy risk in some studies, though this may reflect confounding by indication 3
  • Maintain pyridoxine doses well below the toxic threshold: the upper tolerable limit is 100 mg/day for adults, though toxicity can occur at this level with prolonged use 5

Practical Administration

  • Divide the total daily pyridoxine dose into 2–4 administrations to improve tolerability and maintain steady levels 1
  • For 100 mg daily using 5 mg/mL syrup: give 5 mL four times daily (20 mL total)
  • For 150 mg daily: give 7.5 mL four times daily (30 mL total)
  • Administer with or after feeds to minimize gastrointestinal upset

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021

Guideline

Treatment of Vitamin B6 Toxicity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

For an 8.3 kg infant receiving cycloserine, is a daily dose of 2.5 mL of B‑complex (containing 5 mg pyridoxine per mL) appropriate?
Which pyridoxine (vitamin B6) oral solution brands are available for an infant requiring 10–25 mg daily supplementation during cycloserine therapy?
In a 12‑month‑old (8.3 kg) child receiving levofloxacin, cycloserine, and clofazimine for multidrug‑resistant tuberculosis, does a standard over‑the‑counter multivitamin provide an adequate pyridoxine (vitamin B6) dose to prevent cycloserine‑induced neurotoxicity?
In a 12‑month‑old, 8 kg infant who is in month 10 of a multidrug‑resistant tuberculosis regimen that includes cycloserine, can pyridoxine (vitamin B6) be started now for neuroprotection?
What is the appropriate daily pyridoxine (vitamin B6) dose in milligrams for an 8.3 kg infant receiving cycloserine?
What is the recommended first-line management for a 6-month-old infant presenting with cough and cold?
What is the appropriate outpatient management for a patient with mild epiglottic and glottic arytenoid thickening presenting with odynophagia and no airway compromise?
Is carrot a low‑FODMAP food?
What is the definition and diagnostic criteria for preterm labour?
How should degenerative lumbar spine osteoarthropathy (spondylosis) be initially managed?
What is the most likely diagnosis and recommended management for an adult with acute food‑borne gastroenteritis presenting with fever, watery diarrhea, abdominal cramping and nausea/vomiting?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.